Article Text

other Versions

PDF
Stability of the m.8893T>G mtDNA mutation load during human embryofetal development has implications for the feasibility of prenatal diagnosis in NARP syndrome
  1. Julie Steffann (steffann{at}necker.fr)
  1. Groupe Hospitalier Necker - Enfants Malades, France
    1. Nadine Gigarel
    1. Groupe Hospitalier Necker - Enfants Malades, France
      1. Johanna Corcos
      1. Groupe Hospitalier Necker - Enfants Malades, France
        1. Maryse Bonniere Darcy
        1. Groupe Hospitalier Necker - Enfants Malades, France
          1. Férechté Encha-Razavi
          1. Groupe Hospitalier Necker - Enfants Malades, France
            1. Martine Sinico
            1. centre hospitalier intercommunal de Créteil, France
              1. Sophie Prevot
              1. hôpital Antoine-Beclere, France
                1. Yves Dumez
                1. Groupe Hospitalier Necker - Enfants Malades, France
                  1. Amina Yamgnane
                  1. Groupe Hospitalier Necker - Enfants Malades, France
                    1. René Frydman
                    1. Hôpital Antoine-Béclère, France
                      1. Arnold Munnich (munnich{at}necker.fr)
                      1. Groupe Hospitalier Necker - Enfants Malades, France
                        1. Jean-Paul Bonnefont
                        1. Groupe Hospitalier Necker - Enfants Malades, France

                          Abstract

                          Introduction: Mitochondrial DNA (mtDNA) mutations cause a wide range of serious genetic diseases with maternal inheritance. Due to a high transmission risk and the absence of therapy in these disorders, “at risk” couples often ask for prenatal diagnosis (PND). However, because loads of heteroplasmy (coexistence of mutant and wild type mtDNA) may vary among tissues and with time, the possibility that a single fetal sample may not reflect the whole neonate impedes prenatal diagnosis of mtDNA diseases.

                          Methods: We carried out 13 prenatal diagnoses for the NARP (Neurogenic weakness, Ataxia, Retinitis Pigmentosa) m.8993T>G mtDNA mutation (p.Leu156Arg) in the ATP synthase subunit 6 gene. Analyses were performed on chorionic villous (CVS) and/or amniocytes (AS) samples carried out at various stages of pregnancy, using a method enabling quantification of low DNA amounts.

                          Results: Maternal mutant loads ranged from 0 to 75% in blood and had no predictive value for the fetus status, except for women with no detectable mutant DNA, whose fetuses were constantly mutation free. In 8/13 PND, mutant load was below 30%. These children are healthy at 2 to 7 years of age. In 5/13 PND, mutant load ranged from 65 to 100% and parents preferred to terminate the pregnancies (15-22 weeks of gestation). Single-cell analysis of 20 trophoblastic cells and 21 amniocytes isolated from two affected fetuses found an average mutant load close to the overall CVS and AS mutant load, despite striking intercellular variation. m.8993T>G mutant loads, assessed in 7, 17, 11, and 5 different tissues from 4 abortions, were identical in all tissues from a given individual (mean 78±1.2%, 91±0.7%, 74±2%, and 63±1.6% for the 4 fetuses, respectively).

                          Conclusions: Our results indicate that the placental/amniotic mutant loads do reflect the NARP mutant mtDNA load in the whole fetus, even when the sample amount is small, and suggest that heteroplasmy level remains stable during pregnancy, at least after 10 weeks of gestation. While these data establish the feasibility of PND for this mutation, assessing more precisely the correlation between mutant load and disease severity should further help interpreting PND results.

                          • NARP syndrome
                          • development
                          • heteroplasmy
                          • m.8993T>G
                          • prenatal diagnosis

                          Statistics from Altmetric.com

                          Request permissions

                          If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.